Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma.
Collin K ChinMaria A RodriguezYun QingLei FengFelipe SamaniegoPreetesh JainMansoor NooraniNathan Hale FowlerLuis E FayadJason R WestinSattva S NeelapuFrederick B HagemeisterChristopher R FlowersLoretta J NastoupilPublished in: Leukemia & lymphoma (2020)